stoxline Quote Chart Rank Option Currency Glossary
  
Avinger, Inc. (AVGR)
0.46  0.01 (2.22%)    02-12 19:59
Open: 0.432
High: 0.485
Volume: 3,656,945
  
Pre. Close: 0.45
Low: 0.3977
Market Cap: 2(M)
Technical analysis
2025-02-12 4:43:10 PM
Short term     
Mid term     
Targets 6-month :  0.75 1-year :  0.96
Resists First :  0.64 Second :  0.82
Pivot price 0.51
Supports First :  0.36 Second :  0.3
MAs MA(5) :  0.43 MA(20) :  0.52
MA(100) :  0.77 MA(250) :  1.77
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  34.9 D(3) :  27.3
RSI RSI(14): 42.2
52-week High :  5.44 Low :  0.36
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ AVGR ] has closed above bottom band by 32.7%. Bollinger Bands are 25.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.49 - 0.49 0.49 - 0.49
Low: 0.39 - 0.39 0.39 - 0.4
Close: 0.46 - 0.46 0.46 - 0.46
Company Description

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was incorporated in 2007 and is headquartered in Redwood City, California.

Headline News

Wed, 05 Feb 2025
Avinger Inc shareholders approve liquidation plan - Investing.com

Mon, 27 Jan 2025
Avinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. Patents - ACCESS Newswire

Fri, 24 Jan 2025
Avinger Inc adjourns Special Meeting due to lack of quorum - MSN

Tue, 24 Dec 2024
This Healthcare Stock Massively Outperformed The Market Before The Holiday - The Globe and Mail

Tue, 24 Dec 2024
TSLA, AVGR, JTAI, TEVA, NFLX: Top 5 Trending Stocks Today - Jet AI (NASDAQ:JTAI), Avinger (NASDAQ:AVGR) - Benzinga

Thu, 19 Dec 2024
Avinger’s 2024 Stockholder Meeting and Director Elections - TipRanks

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 0 (M)
Shares Float 3 (M)
Held by Insiders 1.88e+006 (%)
Held by Institutions 13.6 (%)
Shares Short 93 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -1.755e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin -260.9 %
Operating Margin -223.5 %
Return on Assets (ttm) -65.3 %
Return on Equity (ttm) -3 %
Qtrly Rev. Growth 7.43e+006 %
Gross Profit (p.s.) -8.19
Sales Per Share 286.71
EBITDA (p.s.) 1.27586e+006
Qtrly Earnings Growth -8.8 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -15 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow -0.12
Stock Dividends
Dividend 0
Forward Dividend 122400
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android